Insider Trading History of Meckler Jeffrey A

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Meckler Jeffrey A since 2013. This trader's CIK number is 1506916. At the time of last reporting, Meckler Jeffrey A was the Officer of Travere Therapeutics, Inc.. (stock ticker symbol TVTX). Also see all insider trading activities at Travere Therapeutics, Inc..

Note that in the past Meckler Jeffrey A also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Intec Pharma Ltd. (NTEC) by Meckler Jeffrey A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 NTEC 120,000 $59,320 0 $0 0 $0

Yearly summary of insider trading at Indaptus Therapeutics, Inc. (INDP) by Meckler Jeffrey A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 INDP 49,727 $124,459 0 $0 0 $0
2021 INDP 23,187 $149,108 0 $0 0 $0

Yearly summary of insider trading at Novelion Therapeutics Inc. (QLTI) by Meckler Jeffrey A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 QLTI 0 $0 0 $0 35,000 $87,125
2014 QLTI 20,000 $72,000 0 $0 2,000 $0
2013 QLTI 50,000 $290,000 0 $0 0 $0

Yearly summary of insider trading at Travere Therapeutics, Inc. (TVTX) by Meckler Jeffrey A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 TVTX 0 $0 40,000 $562,320 40,000 $419,200
2016 TVTX 5,000 $76,565 0 $0 0 $0
2014 TVTX 15,000 $129,045 0 $0 0 $0

Yearly summary of insider trading at Cocrystal Pharma, Inc. (COCP) by Meckler Jeffrey A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 COCP 294,118 $150,000 0 $0 0 $0
2015 COCP 263,043 $207,898 0 $0 0 $0
2014 COCP 100,000 $45,500 0 $0 0 $0


Insider trading activities at 5 companies by Meckler Jeffrey A:

1. Intec Pharma Ltd. (NTEC)

2. Indaptus Therapeutics, Inc. (INDP)

3. Novelion Therapeutics Inc. (QLTI)

4. Travere Therapeutics, Inc. (TVTX)

5. Cocrystal Pharma, Inc. (COCP)

Table 1. Insider trading of Intec Pharma Ltd. (NTEC) by Meckler Jeffrey A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-08-28 NTEC Buy 20,000 .68 13,620
2019-08-23 NTEC Buy 100,000 .46 45,700

Table 2. Insider trading of Indaptus Therapeutics, Inc. (INDP) by Meckler Jeffrey A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-11-18 INDP Buy 400 1.76 705
2022-11-21 INDP Buy 9,600 1.90 18,240
2022-09-08 INDP Buy 10,308 2.80 28,862
2022-09-07 INDP Buy 8,632 2.57 22,184
2022-09-06 INDP Buy 1,060 2.44 2,586
2022-06-06 INDP Buy 19,727 2.63 51,882
2021-11-18 INDP Buy 11,187 5.82 65,108
2021-09-14 INDP Buy 12,000 7.00 84,000

Table 3. Insider trading of Novelion Therapeutics Inc. (QLTI) by Meckler Jeffrey A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-06-29 QLTI Option Ex 25,000 3.48 87,125
2015-06-07 QLTI Option Ex 10,000 .00 0
2014-12-18 QLTI Buy 20,000 3.60 72,000
2014-12-15 QLTI Option Ex 2,000 .00 0
2013-06-28 QLTI Buy 30,000 4.36 130,800
2013-05-03 QLTI Buy 20,000 7.96 159,200

Table 4. Insider trading of Travere Therapeutics, Inc. (TVTX) by Meckler Jeffrey A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-09-30 TVTX Option Ex 40,000 10.48 419,200
2024-09-30 TVTX Sale 40,000 14.06 562,320
2016-03-04 RTRX Buy 5,000 15.31 76,565
2014-11-25 RTRX Buy 15,000 8.60 129,045

Table 5. Insider trading of Cocrystal Pharma, Inc. (COCP) by Meckler Jeffrey A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-03-15 COCP Buy 294,118 .51 150,000
2015-12-23 COCP Buy 100,000 .58 57,899
2015-03-25 COCP Buy 163,043 .92 149,999
2014-12-11 COCP Buy 100,000 .46 45,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Meckler Jeffrey A (Officer of Travere Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.